Esperion Therapeutics Inc (STU:0ET) Stock News, Headlines & Updates
Esperion Therapeutics Inc Stock News from GuruFocus
- 1
May 23, 2024
Esperion to Participate in Upcoming June Investor Conferences
Marketwired • 8:00am
May 20, 2024
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia
Marketwired • 5:00am
May 14, 2024
Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET®
Marketwired • 7:00am
May 10, 2024
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwired • 3:00pm
May 08, 2024
Esperion Therapeutics Inc (ESPR) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and Strategic Advances
GuruFocus Research • 1:04am
Q1 2024 Esperion Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:11pm
May 07, 2024
Esperion Therapeutics Inc (ESPR) Surpasses Q1 Revenue Forecasts with a 467% Increase
GuruFocus Research • 6:55am
Esperion Reports First Quarter 2024 Financial Results
Marketwired • 5:00am
Apr 29, 2024
Esperion to Participate in Upcoming May Investor Conferences
Marketwired • 7:00am
Apr 23, 2024
Esperion to Report First Quarter 2024 Financial Results on May 7
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news